Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,501 JPY | -3.91% | -1.51% | +5.63% |
04-18 | Nxera Pharma Initiates Restricted Stock Unit Plans, Starting with Shares Worth 164 Million Yen in Total in May | MT |
04-17 | Nxera Pharma's Neuro Drug NBI-1117568 Passed Preclinical Toxicity Test | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.63% | 893M | |
-1.26% | 89.46B | |
+2.76% | 40.74B | |
-9.44% | 33.03B | |
+55.32% | 24.68B | |
-16.27% | 15.12B | |
-9.09% | 12.81B | |
-12.11% | 11.79B | |
-43.61% | 11.64B | |
+7.79% | 8.9B |
- Stock Market
- Equities
- 4565 Stock
- News Nxera Pharma Co., Ltd.
- Transcript : Sosei Group Corporation Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 01